LLY vs COR
By Alex · Tickerpine
Eli Lilly and Company vs Cencora, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | COR |
|---|---|---|
| Price | $1,183.46 | $306.92 |
| Market cap | $1.06T | $58.57B |
| P/E ratio | 39.7 | 22.8 |
| ROE | 102.29% | 96.87% |
| Profit margin | 33.53% | 0.79% |
| Revenue growth | 47.70% | 5.10% |
| Dividend yield | 0.58% | 0.78% |
| Beta | 0.50 | 0.57 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs COR in plain English
- LLY is the bigger company — about 18.0× the market cap of COR.
- COR is cheaper on earnings (P/E 22.8 vs 39.7).
- LLY earns a higher return on equity (102% vs 97%).
- LLY is growing revenue faster (48% vs 5%).
- COR has the higher dividend yield (0.78% vs 0.58%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
COR return calculator
See what $1,000 in Cencora, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.